A Plant Compound from Ginseng May Help Slow Aging in the Uterus

Scientists in Beijing, China, have discovered that a natural compound found in ginseng — a plant long used in traditional medicine — may help slow aging in the uterus. The compound, called Ginsenoside Rb1, or simply Rb1, was tested on human cells and aging mice. Researchers found it reduced signs of aging and may help women over 35 have better chances of getting pregnant. The study was published in a scientific journal called Signal Transduction and Targeted Therapy.

More women today are waiting until they are older to have children. This is happening because of changes in education, careers, and the growth of medical treatments that help people become pregnant. However, getting pregnant becomes harder as women age — and it is not just because of aging eggs. The uterus, which is where a baby grows, also changes with age in ways that make pregnancy more difficult.

The inner lining of the uterus is called the endometrium. It has special cells called endometrial stromal cells, or EnSCs, that play a big role in helping an embryo attach and grow. As women get older, these cells start to 'age' in a way that scientists call senescence. Senescent cells stop working the way they should, release harmful chemicals, and have trouble doing their jobs.

The researchers looked at data from over 1,100 patients who went through a process that tested their embryos for genetic problems before placing them in the uterus. Even after choosing only healthy embryos, older women still had lower rates of pregnancy and live births. This told scientists that the uterus itself — not just the embryo — plays a big role in whether a pregnancy succeeds.

Ginseng is a plant that has been used in traditional medicine for thousands of years. It contains natural chemicals called ginsenosides, and Rb1 is the most common one. Past research showed that Rb1 can reduce inflammation, lower damage caused by stress inside cells, and slow aging in other parts of the body. Scientists wondered if it could do the same for the uterus.

To find out, the team collected endometrial cells from younger women and older women and treated the older cells with Rb1. The results were encouraging — the Rb1 treatment reduced signs of cellular aging and lowered harmful stress levels inside the cells. It also decreased the rate at which cells were dying off early, a process called apoptosis. This suggested Rb1 could fight the damage that comes with aging in uterine cells.

The scientists also tested Rb1 on aging mice and found that treated mice had more successful pregnancies. More places in the uterus where embryos could attach appeared, and important markers showing the uterus was ready for pregnancy went back up. The ability of stromal cells to transform properly — a process called decidualization — also improved with Rb1 treatment.

So how does Rb1 work inside cells? The researchers found a chain of molecular events involving three key proteins. First, Rb1 connects to a protein called AMPK, which acts like an energy sensor. When Rb1 activates AMPK, it turns off another protein called mTOR, which when left on too long causes inflammation and more cell aging. This then stops a third protein, NF-κB, from moving into the cell's nucleus and causing more harm.

The researchers confirmed this step-by-step process in several ways. When they blocked AMPK on purpose, Rb1 stopped working, proving that AMPK is the crucial first step. Similarly, when mTOR was forced to stay active, Rb1 could no longer stop the inflammation caused by NF-κB. These tests gave strong evidence that the AMPK/mTOR/NF-κB chain is how Rb1 fights uterine aging.

Safety was also checked carefully. Rb1 did not appear to harm human cells, even at higher doses, and blood and organ tests in mice showed no harmful effects after two weeks of treatment. The researchers said that longer studies will be needed to fully confirm safety before Rb1 could be used as a medicine. Still, the early results are promising for future research into natural treatments for aging-related fertility problems.